Matches in Wikidata for { <http://www.wikidata.org/entity/Q69100430> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q69100430 description "article scientifique publié en 1989" @default.
- Q69100430 description "artículu científicu espublizáu n'agostu de 1989" @default.
- Q69100430 description "im August 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69100430 description "scientific article published on 01 August 1989" @default.
- Q69100430 description "wetenschappelijk artikel" @default.
- Q69100430 description "наукова стаття, опублікована в серпні 1989" @default.
- Q69100430 name "Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing" @default.
- Q69100430 name "Cardiovascular effects and plasma level profile of pimobendan" @default.
- Q69100430 type Item @default.
- Q69100430 label "Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing" @default.
- Q69100430 label "Cardiovascular effects and plasma level profile of pimobendan" @default.
- Q69100430 prefLabel "Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing" @default.
- Q69100430 prefLabel "Cardiovascular effects and plasma level profile of pimobendan" @default.
- Q69100430 P1433 Q69100430-D7536C6C-6C01-4B6E-8F0B-1EDB0F309C33 @default.
- Q69100430 P1476 Q69100430-D0ECA167-6B05-4404-A32E-CEF0FE10A4D0 @default.
- Q69100430 P2093 Q69100430-60646CB1-B738-4ADB-B0E4-196E0FDBE293 @default.
- Q69100430 P2093 Q69100430-7F6E9975-8324-4085-9EB8-CE62135A2B87 @default.
- Q69100430 P2093 Q69100430-E1B93CF0-9B56-4416-A84F-51467495E737 @default.
- Q69100430 P304 Q69100430-29C06EDE-015B-4615-9EA3-679455F684C8 @default.
- Q69100430 P31 Q69100430-DB836351-0816-4A89-B433-05EEEBD04BA3 @default.
- Q69100430 P356 Q69100430-2AF66B85-7FB7-4D19-9056-210AE1E55277 @default.
- Q69100430 P407 Q69100430-1E7B1CFB-B437-42FD-A372-A61DC5605493 @default.
- Q69100430 P433 Q69100430-779290C5-94F7-480C-88C9-765750439A7D @default.
- Q69100430 P478 Q69100430-11A07A50-E06F-42AE-8A8C-70651B25AADB @default.
- Q69100430 P577 Q69100430-D3F4CCA6-520D-4C01-A23C-48903D7C793A @default.
- Q69100430 P698 Q69100430-3FF713E2-17C2-4329-863E-161AE84A790E @default.
- Q69100430 P921 Q69100430-4A61E648-A6BB-4EF0-9296-D5E60381B333 @default.
- Q69100430 P356 00005344-198908000-00018 @default.
- Q69100430 P698 2476606 @default.
- Q69100430 P1433 Q2125808 @default.
- Q69100430 P1476 "Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing" @default.
- Q69100430 P2093 "F Hagemeijer" @default.
- Q69100430 P2093 "H J Brand" @default.
- Q69100430 P2093 "W Roth" @default.
- Q69100430 P304 "302-310" @default.
- Q69100430 P31 Q13442814 @default.
- Q69100430 P356 "10.1097/00005344-198908000-00018" @default.
- Q69100430 P407 Q1860 @default.
- Q69100430 P433 "2" @default.
- Q69100430 P478 "14" @default.
- Q69100430 P577 "1989-08-01T00:00:00Z" @default.
- Q69100430 P698 "2476606" @default.
- Q69100430 P921 Q19000661 @default.